 |
Recombinant human thrombopoietin |
|---|---|
| Trade Name | |
| Orphan Indication | For use in accelerating platelet recovery in patients undergoing hematopoietic stem cell transplantation |
| USA Market Approval | USA |
| USA Designation Date | 1997-09-29 00:00:00 |
| Sponsor | Genentech, Inc.;1 DNA Way;South San Francisco, California, 94080 |
